
Jiangsu Hengrui Medicine Co., Ltd.
600276.SS
54.5
CNY-1.10
(-1.98%)Day's range
54.3
56
52 wk Range
37.24
57.53
Key ratios
Statements Highlights
Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
---|---|---|---|---|---|---|
Total Revenue | 27,734,598,747 | 25,905,526,375 | 21,275,270,681 | 22,819,784,741 | 27,984,605,342 | |
Gross Profit | 24,385,909,078 | 22,163,727,825 | 17,788,631,791 | 19,294,536,955 | 24,136,427,951 | |
Operating Income | 7,007,072,303 | 4,664,816,127 | 4,111,959,971 | 4,909,904,926 | 7,490,632,003 | |
Net Income | 6,328,383,219 | 4,530,217,550 | 3,906,375,067 | 4,302,435,930 | 6,336,527,014 | |
Total Assets | 34,729,589,915 | 39,266,221,700 | 42,355,009,127 | 43,784,506,635 | 50,135,645,304 | |
Total Current Liabilities | 3,771,593,066 | 3,401,532,454 | 3,639,219,602 | 2,553,658,628 | 3,633,595,722 | |
Total Equity | 30,787,001,938 | 35,571,807,926 | 38,413,156,142 | 41,033,086,440 | 46,090,250,732 | |
Free Cash Flow | 2,877,606,274 | 2,554,180,820 | -726,913,080.16 | 6,159,873,329 | 5,453,555,550 | |
Cash from Operations | 3,431,934,805 | 4,218,816,053 | 1,265,264,631 | 7,643,665,074 | 7,422,753,038 | |
Cash from Investing | 1,797,828,788 | -546,263,028.9 | 390,289,366 | 1,222,315,107 | -1,911,985,716.23 | |
Cash from Financing | 291,188,280 | -998,321,816.5 | -318,770,209.45 | -3,144,426,297 | -1,550,590,025.88 | |
Net Change in Cash | 5,431,873,022 | 2,657,364,767 | 1,417,281,160 | 5,734,087,021 | 3,967,577,847 |